{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T23:16:58Z","timestamp":1788045418507,"version":"build-2784847793"},"reference-count":107,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Journal"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bj.2025.100906","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T09:10:10Z","timestamp":1755508210000},"page":"100906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Plasminogen activator Inhibitor-1 in systemic sclerosis: A nexus of fibrosis, vasculopathy, and senescence"],"prefix":"10.1016","volume":"49","author":[{"given":"Takuya","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5560-9778","authenticated-orcid":false,"given":"Yoshihide","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10373","key":"10.1016\/j.bj.2025.100906_bib1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bj.2025.100906_bib2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/1346-8138.14153","article-title":"Systemic sclerosis","volume":"45","author":"Asano","year":"2018","journal-title":"J Dermatol"},{"issue":"11","key":"10.1016\/j.bj.2025.100906_bib3","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.bj.2025.100906_bib4","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1136\/annrheumdis-2015-208121","article-title":"Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO Registry","volume":"75","author":"Matucci-Cerinic","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.bj.2025.100906_bib5","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.molmed.2024.05.012","article-title":"Senescence and tissue fibrosis: opportunities for therapeutic targeting","volume":"30","author":"O\u2019Reilly","year":"2024","journal-title":"Trends Mol Med"},{"issue":"2","key":"10.1016\/j.bj.2025.100906_bib6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jcp.22783","article-title":"PAI-1 in tissue fibrosis","volume":"227","author":"Ghosh","year":"2012","journal-title":"J Cell Physiol"},{"issue":"5","key":"10.1016\/j.bj.2025.100906_bib7","doi-asserted-by":"crossref","first-page":"L740","DOI":"10.1152\/ajplung.00146.2010","article-title":"Hypoxia-inducible factor-1\u03b1 mediates TGF-\u03b2-induced PAI-1 production in alveolar macrophages in pulmonary fibrosis","volume":"300","author":"Ueno","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"10","key":"10.1016\/j.bj.2025.100906_bib8","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1590\/1414-431X20133061","article-title":"Morphometric evaluation of nitric oxide synthase isoforms and their cytokine regulators predict pulmonary dysfunction and survival in systemic sclerosis","volume":"46","author":"Parra","year":"2013","journal-title":"Braz J Med Biol Res"},{"issue":"14","key":"10.1016\/j.bj.2025.100906_bib9","first-page":"5587","article-title":"Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin","volume":"61","author":"Isogai","year":"2001","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.bj.2025.100906_bib10","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1111\/jth.13869","article-title":"Plasminogen activator inhibitor-1 regulates the vascular expression of vitronectin","volume":"15","author":"Luo","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.bj.2025.100906_bib11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.cardiores.2004.11.013","article-title":"Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly","volume":"66","author":"Yamamoto","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.bj.2025.100906_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.845956","article-title":"The uPA system differentially alters fibroblast fate and profibrotic ability in skin fibrosis","volume":"13","author":"Zou","year":"2022","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.bj.2025.100906_bib13","first-page":"1056","article-title":"Impact of plasminogen activator inhibitor-1 serum levels and the -675 4G\/5G variant in the SERPINE1 gene on systemic sclerosis in a Mexican population","volume":"14","author":"Lomel\u00ed-Nieto","year":"2024","journal-title":"Life (Basel)"},{"issue":"5","key":"10.1016\/j.bj.2025.100906_bib14","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/rheumatology\/kel451","article-title":"Skin involvement in scleroderma--where histological and clinical scores meet","volume":"46","author":"Verrecchia","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.bj.2025.100906_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/BOR.0000000000000963","article-title":"The contribution of endothelial cells to tissue fibrosis","volume":"36","author":"Romano","year":"2024","journal-title":"Curr Opin Rheumatol"},{"issue":"(3):619","key":"10.1016\/j.bj.2025.100906_bib16","article-title":"The role of fibrinolytic regulators in vascular dysfunction of systemic sclerosis","volume":"20","author":"Kanno","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.bj.2025.100906_bib17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/art.39443","article-title":"Resolution of skin fibrosis by neutralization of the antifibrinolytic function of plasminogen activator inhibitor 1","volume":"68","author":"Lemaire","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.bj.2025.100906_bib18","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/ATVBAHA.117.309451","article-title":"Plasminogen activator inhibitor-1 is a marker and a mediator of senescence","volume":"37","author":"Vaughan","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.bj.2025.100906_bib19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1165\/rcmb.2019-0071OC","article-title":"PAI-1 regulation of TGF-\u03b21-induced alveolar type II cell senescence, SASP secretion, and SASP-mediated activation of alveolar macrophages","volume":"62","author":"Rana","year":"2020","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"10.1016\/j.bj.2025.100906_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-0042-1758791","article-title":"Past, present, and future perspectives of plasminogen activator inhibitor 1 (PAI-1)","volume":"49","author":"Morrow","year":"2023","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.bj.2025.100906_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fonc.2018.00024","article-title":"Multifaceted role of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR): diagnostic, prognostic, and therapeutic applications","volume":"8","author":"Mahmood","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.bj.2025.100906_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5417565","article-title":"tPA-MMP-9 Axis plays a pivotal role in mobilization of endothelial progenitor cells from bone marrow to circulation and ischemic region for angiogenesis","volume":"2016","author":"Leu","year":"2016","journal-title":"Stem Cells Int"},{"issue":"4","key":"10.1016\/j.bj.2025.100906_bib23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/thx.2009.119974","article-title":"Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis","volume":"65","author":"Senoo","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.bj.2025.100906_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.exger.2014.11.018","article-title":"Plasminogen activator inhibitor 1, fibroblast apoptosis resistance, and aging-related susceptibility to lung fibrosis","volume":"61","author":"Huang","year":"2015","journal-title":"Exp Gerontol"},{"issue":"2","key":"10.1016\/j.bj.2025.100906_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1096\/fj.01-0552com","article-title":"The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent","volume":"16","author":"Devy","year":"2002","journal-title":"Faseb j"},{"issue":"1","key":"10.1016\/j.bj.2025.100906_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2021.119157","article-title":"Mesenchymal stromal cells enhance self-assembly of a HUVEC tubular network through uPA-uPAR\/VEGFR2\/integrin\/NOTCH crosstalk","volume":"1869","author":"Beloglazova","year":"2022","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"1","key":"10.1016\/j.bj.2025.100906_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrm2821","article-title":"Regulation of cell signalling by uPAR","volume":"11","author":"Smith","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bj.2025.100906_bib28","article-title":"Vascular smooth muscle cells in intimal hyperplasia, an update","volume":"13","author":"D\u00e9glise","year":"2022","journal-title":"Front Physiol"},{"issue":"12","key":"10.1016\/j.bj.2025.100906_bib29","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1016\/S0021-9258(18)60636-2","article-title":"Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor","volume":"263","author":"Schleef","year":"1988","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.bj.2025.100906_bib30","first-page":"270","article-title":"Hypoxia induces endothelial-mesenchymal transition in pulmonary vascular remodeling","volume":"42","author":"Zhang","year":"2018","journal-title":"Int J Mol Med"},{"issue":"1","key":"10.1016\/j.bj.2025.100906_bib31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13046-023-02714-0","article-title":"Cancer-associated fibroblast-derived PAI-1 promotes lymphatic metastasis via the induction of EndoMT in lymphatic endothelial cells","volume":"42","author":"Wei","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.bj.2025.100906_bib32","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/ncb1448","article-title":"Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence","volume":"8","author":"Kortlever","year":"2006","journal-title":"Nat Cell Biol"},{"issue":"36","key":"10.1016\/j.bj.2025.100906_bib33","doi-asserted-by":"crossref","first-page":"24308","DOI":"10.1074\/jbc.M803341200","article-title":"Transforming growth factor-beta requires its target plasminogen activator inhibitor-1 for cytostatic activity","volume":"283","author":"Kortlever","year":"2008","journal-title":"J Biol Chem"},{"issue":"32","key":"10.1016\/j.bj.2025.100906_bib34","doi-asserted-by":"crossref","first-page":"22527","DOI":"10.1074\/jbc.M512819200","article-title":"A novel function of plasminogen activator inhibitor-1 in modulation of the AKT pathway in wild-type and plasminogen activator inhibitor-1-deficient endothelial cells","volume":"281","author":"Balsara","year":"2006","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.bj.2025.100906_bib35","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114146","article-title":"Glomerular endothelial cell senescence drives age-related kidney disease through PAI-1","volume":"13","author":"Cohen","year":"2021","journal-title":"EMBO Mol Med"},{"issue":"19","key":"10.1016\/j.bj.2025.100906_bib36","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.1073\/pnas.1321942111","article-title":"PAI-1-regulated extracellular proteolysis governs senescence and survival in Klotho mice","volume":"111","author":"Eren","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"30","key":"10.1016\/j.bj.2025.100906_bib37","doi-asserted-by":"crossref","first-page":"12052","DOI":"10.1073\/pnas.1120437109","article-title":"Plasminogen activator inhibitor 1--insulin-like growth factor binding protein 3 cascade regulates stress-induced senescence","volume":"109","author":"Elzi","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"482","key":"10.1016\/j.bj.2025.100906_bib38","doi-asserted-by":"crossref","first-page":"eaat0852","DOI":"10.1126\/scitranslmed.aat0852","article-title":"PAI-1 augments mucosal damage in colitis","volume":"11","author":"Kaiko","year":"2019","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.bj.2025.100906_bib39","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1186\/s12877-024-05473-5","article-title":"Older patients affected by COVID-19: investigating the existence of biological phenotypes","volume":"24","author":"Zucchelli","year":"2024","journal-title":"BMC Geriatr"},{"issue":"2","key":"10.1016\/j.bj.2025.100906_bib40","doi-asserted-by":"crossref","first-page":"E260","DOI":"10.1152\/ajpendo.00387.2018","article-title":"Inhibition of PAI-1 attenuates perirenal fat inflammation and the associated nephropathy in high-fat diet-induced obese mice","volume":"316","author":"Liu","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.bj.2025.100906_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1538526","article-title":"IL-6\/GATA2\/SERPINE1 pathway is implicated in regulating cellular senescence after acute kidney injury","volume":"12","author":"Su","year":"2025","journal-title":"Front Mol Biosci"},{"issue":"3","key":"10.1016\/j.bj.2025.100906_bib42","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12016-021-08889-8","article-title":"Current concepts on the pathogenesis of systemic sclerosis","volume":"64","author":"Truchetet","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.bj.2025.100906_bib43","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jaad.2021.10.065","article-title":"Systemic sclerosis in adults. Part I: clinical features and pathogenesis","volume":"87","author":"Jerjen","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.bj.2025.100906_bib44","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S","article-title":"Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts","volume":"44","author":"Arnett","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.bj.2025.100906_bib45","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1038\/s41467-019-12760-y","article-title":"GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways","volume":"10","author":"L\u00f3pez-Isac","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.bj.2025.100906_bib46","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.autrev.2018.11.001","article-title":"Systemic sclerosis and exposure to heavy metals","volume":"18","author":"Marie","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.bj.2025.100906_bib47","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00281-015-0505-5","article-title":"Vasculopathy in scleroderma","volume":"37","author":"Asano","year":"2015","journal-title":"Semin Immunopathol"},{"issue":"3","key":"10.1016\/j.bj.2025.100906_bib48","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","article-title":"Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a delphi consensus study from EULAR scleroderma trials and research group","volume":"70","author":"Avouac","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.bj.2025.100906_bib49","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/ar596","article-title":"Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers","volume":"4","author":"Distler","year":"2002","journal-title":"Arthritis Res"},{"issue":"6a","key":"10.1016\/j.bj.2025.100906_bib50","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1582-4934.2010.01027.x","article-title":"Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis","volume":"14","author":"Manetti","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.bj.2025.100906_bib51","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mvr.2017.04.004","article-title":"Detection of early endothelial damage in patients with Raynaud\u2019s phenomenon","volume":"113","author":"Gualtierotti","year":"2017","journal-title":"Microvasc Res"},{"issue":"Suppl 3","key":"10.1016\/j.bj.2025.100906_bib52","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.5152\/eurjrheum.2019.19158","article-title":"Endothelial cells and endothelial progenitor cells in the pathogenesis of systemic sclerosis","volume":"7","author":"Ota","year":"2020","journal-title":"Eur J Rheumatol"},{"issue":"2","key":"10.1016\/j.bj.2025.100906_bib53","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0002-9343(96)00404-4","article-title":"Antiendothelial cell antibodies: useful markers of systemic sclerosis","volume":"102","author":"Salojin","year":"1997","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.bj.2025.100906_bib54","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H","article-title":"Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95","volume":"43","author":"Sgonc","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.bj.2025.100906_bib55","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/art.21952","article-title":"Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies","volume":"54","author":"Ahmed","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.bj.2025.100906_bib56","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/art.38948","article-title":"Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice","volume":"67","author":"Taniguchi","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.bj.2025.100906_bib57","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.4049\/jimmunol.0901778","article-title":"Cell adhesion molecules regulate fibrotic process via Th1\/Th2\/Th17 cell balance in a bleomycin-induced scleroderma model","volume":"185","author":"Yoshizaki","year":"2010","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.bj.2025.100906_bib58","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/BOR.0000000000000959","article-title":"Pathogenesis of vasculopathy in systemic sclerosis and its contribution to fibrosis","volume":"35","author":"Kawaguchi","year":"2023","journal-title":"Curr Opin Rheumatol"},{"issue":"18","key":"10.1016\/j.bj.2025.100906_bib59","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1016\/j.cell.2024.07.012","article-title":"A systems view of the vascular endothelium in health and disease","volume":"187","author":"Augustin","year":"2024","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bj.2025.100906_bib60","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10456-024-09910-2","article-title":"The role of vasculature and angiogenesis in respiratory diseases","volume":"27","author":"Ackermann","year":"2024","journal-title":"Angiogenesis"},{"issue":"Suppl 3","key":"10.1016\/j.bj.2025.100906_bib61","first-page":"iii26","article-title":"Angiogenesis and vasculogenesis in systemic sclerosis","volume":"45","author":"Distler","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.bj.2025.100906_bib62","first-page":"37","article-title":"Different contributions of angiostatin and endostatin in angiogenesis impairment in systemic sclerosis: a cohort study","volume":"34","author":"Almeida","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.bj.2025.100906_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2023.101849","article-title":"Nailfold capillaroscopy","volume":"37","author":"Smith","year":"2023","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.bj.2025.100906_bib64","first-page":"1529","article-title":"Elevated vascular endothelial growth factor in systemic sclerosis","volume":"30","author":"Choi","year":"2003","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.bj.2025.100906_bib65","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tcm.2012.05.011","article-title":"Impaired angiogenesis in systemic sclerosis: the emerging role of the antiangiogenic VEGF(165)b splice variant","volume":"21","author":"Manetti","year":"2011","journal-title":"Trends Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.bj.2025.100906_bib66","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/annrheumdis-2016-210229","article-title":"Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis","volume":"76","author":"Manetti","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bj.2025.100906_bib67","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.matbio.2016.01.012","article-title":"Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?","volume":"51","author":"Jimenez","year":"2016","journal-title":"Matrix Biol"},{"issue":"7","key":"10.1016\/j.bj.2025.100906_bib68","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/01.ATV.19.7.1768","article-title":"Endothelin-1 enhances plasminogen activator inhibitor-1 production by human brain endothelial cells via protein kinase C-dependent pathway","volume":"19","author":"Zidovetzki","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"32","key":"10.1016\/j.bj.2025.100906_bib69","doi-asserted-by":"crossref","first-page":"24665","DOI":"10.1074\/jbc.M109.091256","article-title":"Plasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt\/beta-catenin signaling","volume":"285","author":"He","year":"2010","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.bj.2025.100906_bib70","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1161\/CIRCULATIONAHA.110.955245","article-title":"Genetic deficiency of plasminogen activator inhibitor-1 promotes cardiac fibrosis in aged mice: involvement of constitutive transforming growth factor-beta signaling and endothelial-to-mesenchymal transition","volume":"122","author":"Ghosh","year":"2010","journal-title":"Circulation"},{"issue":"Pt 3","key":"10.1016\/j.bj.2025.100906_bib71","article-title":"PAI-1 influences and curcumin destabilizes MMP-2, MMP-9 and basement membrane proteins during lung injury and fibrosis","volume":"143","author":"Moideen","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"47","key":"10.1016\/j.bj.2025.100906_bib72","doi-asserted-by":"crossref","first-page":"32628","DOI":"10.1074\/jbc.M114.567792","article-title":"Plasminogen kringle 5 induces endothelial cell apoptosis by triggering a voltage-dependent anion channel 1 (VDAC1) positive feedback loop","volume":"289","author":"Li","year":"2014","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.bj.2025.100906_bib73","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/rheumatology\/36.10.1045","article-title":"The coagulation\/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome","volume":"36","author":"Ames","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.bj.2025.100906_bib74","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/747946","article-title":"Lower extremity ulcers in systemic sclerosis: features and response to therapy","author":"Shanmugam","year":"2010","journal-title":"Int J Rheumatol"},{"issue":"6","key":"10.1016\/j.bj.2025.100906_bib75","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3899\/jrheum.210931","article-title":"Impaired fibrinolysis is linked with digital vasculopathy and onset of new digital ulcers in systemic sclerosis","volume":"49","author":"Colic","year":"2022","journal-title":"J Rheumatol"},{"issue":"2 Pt 1","key":"10.1016\/j.bj.2025.100906_bib76","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1164\/ajrccm.156.2.9608094","article-title":"Tissue factor expression and fibrin deposition in the lungs of patients with idiopathic pulmonary fibrosis and systemic sclerosis","volume":"156","author":"Imokawa","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.bj.2025.100906_bib77","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nrrheum.2009.26","article-title":"Transforming growth factor beta as a therapeutic target in systemic sclerosis","volume":"5","author":"Varga","year":"2009","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.bj.2025.100906_bib78","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/BOR.0000000000000217","article-title":"Origin of fibrosing cells in systemic sclerosis","volume":"27","author":"Ebmeier","year":"2015","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.bj.2025.100906_bib79","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41584-023-01044-x","article-title":"Systemic sclerosis interstitial lung disease: unmet needs and potential solutions","volume":"20","author":"Liakouli","year":"2024","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"10.1016\/j.bj.2025.100906_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103637","article-title":"The intervention of macrophages in progressive fibrosis characterizing systemic sclerosis: a systematic review","volume":"23","author":"Campitiello","year":"2024","journal-title":"Autoimmun Rev"},{"issue":"17","key":"10.1016\/j.bj.2025.100906_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e37192","article-title":"Shaping the immune landscape: multidimensional environmental stimuli refine macrophage polarization and foster revolutionary approaches in tissue regeneration","volume":"10","author":"Xue","year":"2024","journal-title":"Heliyon"},{"issue":"12","key":"10.1016\/j.bj.2025.100906_bib82","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1136\/annrheumdis-2018-213648","article-title":"Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis","volume":"77","author":"Soldano","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.bj.2025.100906_bib83","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.celrep.2018.10.082","article-title":"Plasminogen activator inhibitor-1 promotes the recruitment and polarization of macrophages in cancer","volume":"25","author":"Kubala","year":"2018","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.bj.2025.100906_bib84","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1172\/JCI118396","article-title":"Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene","volume":"97","author":"Eitzman","year":"1996","journal-title":"J Clin Investig"},{"issue":"6","key":"10.1016\/j.bj.2025.100906_bib85","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/j.ajpath.2013.02.039","article-title":"Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension","volume":"182","author":"Ghatnekar","year":"2013","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.bj.2025.100906_bib86","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/MCP.0000000000001001","article-title":"Scleroderma pulmonary arterial hypertension: the same as idiopathic pulmonary arterial hypertension?","volume":"29","author":"Khan","year":"2023","journal-title":"Curr Opin Pulm Med"},{"issue":"5","key":"10.1016\/j.bj.2025.100906_bib87","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/art.37859","article-title":"Thymic stromal lymphopoietin is up-regulated in the skin of patients with systemic sclerosis and induces profibrotic genes and intracellular signaling that overlap with those induced by interleukin-13 and transforming growth factor \u03b2","volume":"65","author":"Christmann","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.bj.2025.100906_bib88","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1172\/JCI99088","article-title":"PAI1 mediates fibroblast-mast cell interactions in skin fibrosis","volume":"128","author":"Pincha","year":"2018","journal-title":"J Clin Investig"},{"issue":"3","key":"10.1016\/j.bj.2025.100906_bib89","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2249.2005.02718.x","article-title":"Plasminogen activator inhibitor-1 is elevated, but not essential, in the development of bleomycin-induced murine scleroderma","volume":"139","author":"Matsushita","year":"2005","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.bj.2025.100906_bib90","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41392-023-01502-8","article-title":"Inflammation and aging: signaling pathways and intervention therapies","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"issue":"2","key":"10.1016\/j.bj.2025.100906_bib91","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12016-022-08943-z","article-title":"Inflammaging and frailty in immune-mediated rheumatic diseases: how to address and score the issue","volume":"64","author":"Salaffi","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"10.1016\/j.bj.2025.100906_bib92","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/BOR.0000000000000898","article-title":"Role of cellular senescence in the pathogenesis of systemic sclerosis","volume":"34","author":"Tsou","year":"2022","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.bj.2025.100906_bib93","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of pulmonary complications and long-term survival in systemic sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.bj.2025.100906_bib94","article-title":"Gene expression meta-analysis reveals aging and cellular senescence signatures in scleroderma-associated interstitial lung disease","volume":"15","author":"Yang","year":"2024","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.bj.2025.100906_bib95","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1021\/acs.nanolett.1c00064","article-title":"Mechanical fingerprint of senescence in endothelial cells","volume":"21","author":"Chala","year":"2021","journal-title":"Nano Lett"},{"issue":"3","key":"10.1016\/j.bj.2025.100906_bib96","first-page":"E84","article-title":"Endothelial cell senescence exacerbates pulmonary fibrosis potentially through accelerated endothelial to mesenchymal transition","volume":"67","author":"Ramadhiani","year":"2021","journal-title":"Kobe J Med Sci"},{"issue":"17","key":"10.1016\/j.bj.2025.100906_bib97","doi-asserted-by":"crossref","first-page":"9497","DOI":"10.1073\/pnas.1918761117","article-title":"Unbiased proteomics identifies plasminogen activator inhibitor-1 as a negative regulator of endothelial nitric oxide synthase","volume":"117","author":"Garcia","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.bj.2025.100906_bib98","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jid.2022.09.652","article-title":"Senescent cells accumulate in systemic sclerosis skin","volume":"143","author":"Shi","year":"2023","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.bj.2025.100906_bib99","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1177\/039463201002300325","article-title":"The plasminogen activator system in fibroblasts from systemic sclerosis","volume":"23","author":"Postiglione","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"9","key":"10.1016\/j.bj.2025.100906_bib100","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1136\/annrheumdis-2013-203706","article-title":"Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?","volume":"73","author":"Manetti","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.bj.2025.100906_bib101","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ccr.2008.08.012","article-title":"Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis","volume":"14","author":"Bajou","year":"2008","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.bj.2025.100906_bib102","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/hh2001.097796","article-title":"Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide","volume":"89","author":"Hoffmann","year":"2001","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.bj.2025.100906_bib103","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/s41591-022-01923-y","article-title":"Cellular senescence and senolytics: the path to the clinic","volume":"28","author":"Chaib","year":"2022","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.bj.2025.100906_bib104","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1002\/cam4.5292","article-title":"Deep molecular response in patients with chronic phase chronic myeloid leukemia treated with the plasminogen activator inhibitor-1 inhibitor TM5614 combined with a tyrosine kinase inhibitor","volume":"12","author":"Takahashi","year":"2023","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.bj.2025.100906_bib105","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/bjd\/ljae231","article-title":"A phase II multicentre study of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab for treating anti-programmed cell death 1 antibody-refractory malignant melanoma: TM5614-MM trial","volume":"191","author":"Fujimura","year":"2024","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.bj.2025.100906_bib106","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41598-023-50445-1","article-title":"A randomized double-blind placebo-controlled trial of an inhibitor of plasminogen activator inhibitor-1 (TM5614) in mild to moderate COVID-19","volume":"14","author":"Hirai","year":"2024","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.bj.2025.100906_bib107","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1365-2516.2008.01834.x","article-title":"Plasminogen activator inhibitor type 1 deficiency","volume":"14","author":"Mehta","year":"2008","journal-title":"Haemophilia"}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417025000800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417025000800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:39:08Z","timestamp":1773304748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2319417025000800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2319417025000800"],"URL":"https:\/\/doi.org\/10.1016\/j.bj.2025.100906","relation":{},"ISSN":["2319-4170"],"issn-type":[{"value":"2319-4170","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasminogen activator Inhibitor-1 in systemic sclerosis: A nexus of fibrosis, vasculopathy, and senescence","name":"articletitle","label":"Article Title"},{"value":"Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bj.2025.100906","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chang Gung University.","name":"copyright","label":"Copyright"}],"article-number":"100906"}}